36 results on '"NISHIOKA, TOMOJI"'
Search Results
2. Hepatitis C Virus Core Protein Modulates Fatty Acid Metabolism and Thereby Causes Lipid Accumulation in the Liver
3. Angiotensin II Participates in Hepatic Inflammation and Fibrosis through MCP-1 Expression
4. A Nuclear Receptor Ligand Down-Regulates Cytosolic Phospholipase A 2 Expression to Reduce Bile Acid–Induced Cyclooxygenase 2 Activity in Cholangiocytes: Implications of Anticarcinogenic Action of Farnesoid X Receptor Agonists
5. Partial characterization of cytoprotective mechanisms of lecithin against bile salt-induced bile duct damage
6. Unique Inhibition of Bile Salt-Induced Apoptosis by Lecithins and Cytoprotective Bile Salts in Immortalized Mouse Cholangiocytes
7. Phospholipid Alterations in Hepatocyte Membranes and Transporter Protein Changes in Cholestatic Rat Model
8. Dose-Dependent Conjugation of Sulfobromophthalein and Hepatic Transit Time in Bile Fistula Rats
9. Role of Phospholipase A2 in Cholesterol Gallstone Formation Is Associated with Biliary Phospholipid Species Selection at the Site of Hepatic Excretion
10. Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage
11. A Nuclear Receptor Ligand Down-Regulates Cytosolic Phospholipase A2 Expression to Reduce Bile Acid–Induced Cyclooxygenase 2 Activity in Cholangiocytes: Implications of Anticarcinogenic Action of Farnesoid X Receptor Agonists
12. Administration of phosphatidylcholine–cholesterol liposomes partially reconstitutes fat absorption in chronically bile-diverted rats
13. Immune response in mouse experimental cholangitis associated with colitis induced by dextran sulfate sodium
14. Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic Gunn rats
15. Impaired gallbladder mucosal function in aged gallstone patients suppresses gallstone recurrence after successful extracorporeal shockwave lithotripsy
16. Inhibition of cholesterol crystallization under bilirubin deconjugation: partial characterization of mechanisms whereby infected bile accelerates pigment stone formation
17. A quantitative assessment of serum chylomicron by light scattering intensity: Application to the intestinal fat absorption test
18. A Nuclear Receptor Ligand Down-Regulates Cytosolic Phospholipase A2 Expression to Reduce Bile Acid?Induced Cyclooxygenase 2 Activity in Cholangiocytes: Implications of Anticarcinogenic Action of Farnesoid X Receptor Agonists
19. A Nuclear Receptor-mediated Choleretic Action of Fibrates is Associated with Enhanced Canalicular Membrane Fluidity and Transporter Activity Mediating Bile Acid-independent Bile Secretion
20. Unique anti-apoptotic action of biliary lecithin against bile acid-induced cholangiocyte apoptosis is based primarily upon the inhibition asbt-mediated uptake and Mrp3-mediated wash-out of bile acids
21. Angiotensin II type la receptor deficient mice show slow progression of liver fibrosis induced by carbon tetrachloride: A direct evidence for fibrogenetic role of renin-angiotensin system
22. A ligand for peroxisome prolifertor-activated receptor gamma inhibits human cholangioma cell growth in association with G1 arrest of cell-cycle and apoptosis: A potential molecular-targetting strategy for cholangioma
23. Cytoprotective action of hydrophilic bile salts is associated with anti-apoptotic effects on cholangiocyte apoptosis induced by cytotoxic bile salts: Implication to clinical use for cholestatic disorder
24. Hydrophilic bile salts cytoprotectively function against cyclosporine A caused cholestasis through enhacing canalicular membrane fluidity and transporter activity
25. Choleretic action of diosgenin is based upon the increases in canalicurar membrane fluidity and transporter activity mediating bile acid independent bile flow
26. Drug-induced stimulation of fecal fat excretion: A novel treatment strategy for unconjugated hyperbilirubinemia?
27. Enteral administration of phosphatidylcholine cholesterol liposomes partially overcomes intestinal fat malabsorption in bile-deficient rats
28. Partial replacement of bile salts causes marked changes of cholesterol crystallization in supersaturated model bile systems
29. A Combination Therapy With Simvastatin and Ursodeoxycholic Acid Is More Effective for Cholesterol Gallstone Dissolution Than Is Ursodeoxycholic Acid Monotherapy
30. Quantitative assessment of comparative potencies of cholesterol-crystal-promoting factors: relation to mechanistic characterization
31. Effects of cerivastatin sodium, a new HMG-CoA reductase inhibitor, on biliary lipid metabolism in patients with hypercholesterolemia
32. A Nuclear Receptor Ligand Down-Regulates Cytosolic Phospholipase A2 Expression to Reduce Bile Acid–Induced Cyclooxygenase 2 Activity in Cholangiocytes: Implications of Anticarcinogenic Action of Farnesoid X Receptor Agonists
33. 391 HCV core protein directly modulates hepatic fatty acid metabolism through enhancing carnitine palmitoyl transferase 1A activity to cause steatosis: relation to compensatory overexpression of rescue molecules, nuclear receptor PPARA and ABC transporter MDR3
34. Tauroursodeoxycholate and taurochenodeoxycholate stabilize bile lipid metastability through different mechanisms: relation to phospholipid fatty acid composition
35. Effect of organic anions on acyl chain composition of secreted biliary lecithin in rats: relation to hepatocellular vesicle pathway
36. [Mechanism of HCV cell entry mediated by envelope and receptor proteins].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.